Steve Poirier

2.3k total citations
20 papers, 1.8k citations indexed

About

Steve Poirier is a scholar working on Surgery, Molecular Biology and Cell Biology. According to data from OpenAlex, Steve Poirier has authored 20 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 9 papers in Molecular Biology and 5 papers in Cell Biology. Recurrent topics in Steve Poirier's work include Lipoproteins and Cardiovascular Health (9 papers), Cellular transport and secretion (4 papers) and Computational Drug Discovery Methods (3 papers). Steve Poirier is often cited by papers focused on Lipoproteins and Cardiovascular Health (9 papers), Cellular transport and secretion (4 papers) and Computational Drug Discovery Methods (3 papers). Steve Poirier collaborates with scholars based in Canada, United States and France. Steve Poirier's co-authors include Nabil G. Seidah, Gaétan Mayer, Annik Prat, Nasha Nassoury, Jadwiga Marcinkiewicz, Ahmed Zaid, Suzanne Benjannet, Harald Mayer, Éric Bergeron and Johannes Nimpf and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and PLoS ONE.

In The Last Decade

Steve Poirier

20 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steve Poirier Canada 15 1.1k 588 324 323 199 20 1.8k
Ann Chamberland Canada 15 1.3k 1.2× 515 0.9× 254 0.8× 335 1.0× 151 0.8× 23 1.8k
Mari Ann Kulseth Norway 17 568 0.5× 489 0.8× 151 0.5× 167 0.5× 180 0.9× 47 1.2k
Derek E. Piper United States 11 379 0.3× 704 1.2× 159 0.5× 158 0.5× 88 0.4× 13 1.3k
Hedy Adari United States 13 276 0.2× 644 1.1× 200 0.6× 96 0.3× 151 0.8× 16 1.2k
Ann L. White United States 26 1.1k 1.0× 1.1k 1.9× 834 2.6× 364 1.1× 254 1.3× 48 2.9k
Eric Wen Su United States 12 64 0.1× 779 1.3× 151 0.5× 106 0.3× 77 0.4× 20 1.2k
Xia Luo China 20 150 0.1× 936 1.6× 315 1.0× 697 2.2× 100 0.5× 48 1.9k
Melissa J. LaBonte United States 27 261 0.2× 1.2k 2.1× 368 1.1× 526 1.6× 90 0.5× 78 2.6k
Paweł K. Mazur United States 22 503 0.5× 1.6k 2.7× 177 0.5× 475 1.5× 154 0.8× 40 2.5k
Caigang Liu China 26 324 0.3× 1.4k 2.4× 291 0.9× 877 2.7× 136 0.7× 132 2.7k

Countries citing papers authored by Steve Poirier

Since Specialization
Citations

This map shows the geographic impact of Steve Poirier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Poirier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Poirier more than expected).

Fields of papers citing papers by Steve Poirier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Poirier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Poirier. The network helps show where Steve Poirier may publish in the future.

Co-authorship network of co-authors of Steve Poirier

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Poirier. A scholar is included among the top collaborators of Steve Poirier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Poirier. Steve Poirier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Poirier, Steve, et al.. (2016). Trafficking Dynamics of PCSK9-Induced LDLR Degradation: Focus on Human PCSK9 Mutations and C-Terminal Domain. PLoS ONE. 11(6). e0157230–e0157230. 31 indexed citations
2.
Viricel, Warren, et al.. (2016). Cationic switchable lipids: pH-triggered molecular switch for siRNA delivery. Nanoscale. 9(1). 31–36. 50 indexed citations
3.
Butkinaree, Chutikarn, Maryssa Canuel, Rachid Essalmani, et al.. (2015). Amyloid Precursor-like Protein 2 and Sortilin Do Not Regulate the PCSK9 Convertase-mediated Low Density Lipoprotein Receptor Degradation but Interact with Each Other. Journal of Biological Chemistry. 290(30). 18609–18620. 42 indexed citations
4.
Poirier, Steve, Maya Mamarbachi, Wan‐Ting Chen, Amy S. Lee, & Gaétan Mayer. (2015). GRP94 Regulates Circulating Cholesterol Levels through Blockade of PCSK9-Induced LDLR Degradation. Cell Reports. 13(10). 2064–2071. 65 indexed citations
5.
Lachance, Christian, Steve Poirier, & Vincent Larivière. (2014). The kiss of death? The effect of being cited in a review on subsequent citations. Journal of the Association for Information Science and Technology. 65(7). 1501–1505. 12 indexed citations
6.
Poirier, Steve, Maya Mamarbachi, Annie Demers, et al.. (2014). The Epigenetic Drug 5-Azacytidine Interferes with Cholesterol and Lipid Metabolism. Journal of Biological Chemistry. 289(27). 18736–18751. 37 indexed citations
7.
Leblond, Agnès, et al.. (2014). The Anti-Hypercholesterolemic Effect of Low p53 Expression Protects Vascular Endothelial Function in Mice. PLoS ONE. 9(3). e92394–e92394. 4 indexed citations
8.
Mayer, Gaétan & Steve Poirier. (2013). The biology of PCSK9 from the endoplasmic reticulum to lysosomes: new and emerging therapeutics to control low-density lipoprotein cholesterol. Drug Design Development and Therapy. 7. 1135–1135. 67 indexed citations
9.
Poirier, Steve, Gaétan Mayer, Stephanie R Murphy, et al.. (2013). The Cytosolic Adaptor AP‐1A Is Essential for the Trafficking and Function of Niemann‐Pick Type C Proteins. Traffic. 14(4). 458–469. 18 indexed citations
10.
Seidah, Nabil G., Steve Poirier, Maxime Denis, et al.. (2012). Annexin A2 Is a Natural Extrahepatic Inhibitor of the PCSK9-Induced LDL Receptor Degradation. PLoS ONE. 7(7). e41865–e41865. 100 indexed citations
11.
Denis, Maxime, Jadwiga Marcinkiewicz, Ahmed Zaid, et al.. (2012). Gene Inactivation of Proprotein Convertase Subtilisin/Kexin Type 9 Reduces Atherosclerosis in Mice. Circulation. 125(7). 894–901. 195 indexed citations
12.
Poirier, Steve, Gaétan Mayer, Viviane Poupon, et al.. (2009). Dissection of the Endogenous Cellular Pathways of PCSK9-induced Low Density Lipoprotein Receptor Degradation. Journal of Biological Chemistry. 284(42). 28856–28864. 223 indexed citations
13.
Seidah, Nabil G., Günter Mayer, Ahmed Zaid, et al.. (2008). The activation and physiological functions of the proprotein convertases. The International Journal of Biochemistry & Cell Biology. 40(6-7). 1111–1125. 253 indexed citations
14.
Mayer, Gaétan, Steve Poirier, & Nabil G. Seidah. (2008). Annexin A2 Is a C-terminal PCSK9-binding Protein That Regulates Endogenous Low Density Lipoprotein Receptor Levels. Journal of Biological Chemistry. 283(46). 31791–31801. 130 indexed citations
15.
Poirier, Steve, Gaétan Mayer, Suzanne Benjannet, et al.. (2007). The Proprotein Convertase PCSK9 Induces the Degradation of Low Density Lipoprotein Receptor (LDLR) and Its Closest Family Members VLDLR and ApoER2. Journal of Biological Chemistry. 283(4). 2363–2372. 381 indexed citations
16.
Poirier, Steve, Annik Prat, Joanne Paquin, et al.. (2006). Implication of the proprotein convertase NARC‐1/PCSK9 in the development of the nervous system. Journal of Neurochemistry. 98(3). 838–850. 99 indexed citations
17.
Poirier, Steve, et al.. (1993). Application of Biotyping and DNA Typing of Candida albicans to the Epidemiology of Recurrent Vulvovaginal Candidiasis. The Journal of Infectious Diseases. 168(2). 502–507. 32 indexed citations
18.
19.
Poirier, Steve, et al.. (1990). Interest of Biotyping Candida albicans in Chronic Vulvovaginitis. Mycoses. 33(1). 24–28. 10 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ann Chamberland Breakdown of academic impact, for papers by Mari Ann Kulseth Breakdown of academic impact, for papers by Derek E. Piper Breakdown of academic impact, for papers by Hedy Adari Breakdown of academic impact, for papers by Ann L. White Breakdown of academic impact, for papers by Eric Wen Su Breakdown of academic impact, for papers by Xia Luo Breakdown of academic impact, for papers by Melissa J. LaBonte Breakdown of academic impact, for papers by Paweł K. Mazur Breakdown of academic impact, for papers by Caigang Liu
Rankless by CCL
2026